HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhiyu Li Selected Research

Glucagon-Like Peptide-1 Receptor

1/20222-Aminothiophene derivatives as a new class of positive allosteric modulators of glucagon-like peptide 1 receptor.
11/2019Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
1/2019Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhiyu Li Research Topics

Disease

125Neoplasms (Cancer)
02/2024 - 10/2008
33Breast Neoplasms (Breast Cancer)
02/2024 - 04/2011
21Neoplasm Metastasis (Metastasis)
05/2023 - 12/2011
18Hepatocellular Carcinoma (Hepatoma)
04/2023 - 12/2010
14Prostatic Neoplasms (Prostate Cancer)
11/2023 - 01/2014
12Inflammation (Inflammations)
03/2024 - 10/2008
9Colorectal Neoplasms (Colorectal Cancer)
05/2023 - 06/2011
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 03/2014
8Leukemia
10/2018 - 09/2009
7Lymphatic Metastasis
12/2023 - 01/2014
7Carcinoma (Carcinomatosis)
12/2023 - 08/2013
7Carcinogenesis
01/2022 - 01/2011
7Hypoxia (Hypoxemia)
06/2019 - 09/2013
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019 - 08/2013
6Colitis
01/2019 - 08/2013
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 06/2013
5Thrombosis (Thrombus)
11/2023 - 04/2015
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 09/2009
4Fibrosis (Cirrhosis)
05/2024 - 09/2014
4Infections
03/2024 - 01/2022
4Non-alcoholic Fatty Liver Disease
01/2024 - 08/2021
4Bites and Stings (Sting)
12/2023 - 01/2020
4Hemangioma (Angioma)
12/2023 - 09/2019
4Myeloid Leukemia (Leukemia, Myelocytic)
01/2022 - 11/2014
4Liver Neoplasms (Liver Cancer)
01/2020 - 04/2002
4Hemorrhage
01/2017 - 04/2015
4Colonic Neoplasms (Colon Cancer)
03/2016 - 08/2012
3Cholangiocarcinoma
04/2024 - 03/2020
3Hyperlipidemias (Hyperlipidemia)
04/2024 - 08/2021
3Lung Neoplasms (Lung Cancer)
02/2024 - 12/2016
3Esophageal Squamous Cell Carcinoma
07/2023 - 01/2023
3Osteoporosis
10/2022 - 04/2020
3Macular Degeneration (Age-Related Maculopathy)
01/2022 - 07/2011
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2019
3Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 01/2018
3Papillary Thyroid Cancer
06/2019 - 03/2011
3Body Weight (Weight, Body)
08/2017 - 04/2016
3Uveitis
04/2016 - 06/2013
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2010 - 10/2008
2Pituitary Neoplasms (Pituitary Adenoma)
03/2024 - 01/2022
2Liver Diseases (Liver Disease)
01/2024 - 01/2024
2Hepatitis
01/2024 - 10/2022

Drug/Important Bio-Agent (IBA)

30FlavonoidsIBA
11/2023 - 06/2011
23Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2002
22wogoninIBA
01/2022 - 12/2010
175,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
12/2019 - 01/2012
8Biomarkers (Surrogate Marker)IBA
05/2024 - 04/2016
8Antineoplastic Agents (Antineoplastics)IBA
12/2023 - 03/2012
8Androgen Receptors (Androgen Receptor)IBA
09/2023 - 01/2014
7Glucose (Dextrose)FDA LinkGeneric
11/2023 - 06/2013
6Phosphotransferases (Kinase)IBA
03/2024 - 10/2013
6EnzymesIBA
01/2023 - 01/2014
6Peptides (Polypeptides)IBA
01/2022 - 01/2013
5Glutamine (L-Glutamine)FDA Link
03/2024 - 01/2019
5GlutaminaseIBA
01/2023 - 11/2019
5Lactic Acid (Lactate)FDA LinkGeneric
01/2020 - 05/2015
5CateninsIBA
01/2020 - 10/2013
5Dextran SulfateIBA
01/2019 - 09/2015
4CholesterolIBA
04/2024 - 12/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 09/2015
4enzalutamideIBA
11/2022 - 01/2016
4ElementsIBA
01/2022 - 12/2011
4CytokinesIBA
06/2021 - 08/2013
4AndrogensIBA
05/2021 - 01/2016
4wogonosideIBA
10/2019 - 06/2016
4Fatty Acids (Saturated Fatty Acids)IBA
02/2019 - 08/2002
4LYG 202IBA
01/2018 - 01/2010
4PiperazineIBA
01/2018 - 01/2009
4Messenger RNA (mRNA)IBA
01/2018 - 12/2011
3RNA (Ribonucleic Acid)IBA
05/2024 - 04/2023
3Long Noncoding RNAIBA
05/2024 - 06/2019
3LipidsIBA
01/2024 - 08/2021
3AcidsIBA
01/2024 - 07/2011
3Citric Acid (Citrate)FDA LinkGeneric
12/2023 - 08/2021
3ThiohydantoinsIBA
09/2023 - 01/2017
3InterferonsIBA
04/2023 - 01/2020
3AlbuminsIBA
04/2023 - 03/2013
3DNA (Deoxyribonucleic Acid)IBA
12/2022 - 05/2015
3Glucagon-Like Peptide-1 ReceptorIBA
01/2022 - 01/2019
3MicroRNAs (MicroRNA)IBA
01/2022 - 06/2019
3fibrin fragment D (D-dimer)IBA
04/2021 - 07/2019
3NF-E2-Related Factor 2IBA
04/2021 - 11/2014
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 08/2013
3LL202 flavonoidIBA
01/2019 - 07/2014
3Androgen Receptor AntagonistsIBA
01/2018 - 01/2014
3oroxylin A-7-O-glucuronideIBA
01/2018 - 04/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 08/2014
3IntegrinsIBA
09/2015 - 12/2011
2Matrix Metalloproteinases (MMPs)IBA
04/2024 - 01/2014
2GoldIBA
01/2024 - 07/2015
2Serine (L-Serine)FDA Link
01/2024 - 01/2021
2SeleniumIBA
12/2023 - 11/2022

Therapy/Procedure

36Therapeutics
04/2024 - 04/2002
8Immunotherapy
04/2023 - 01/2015
8Drug Therapy (Chemotherapy)
01/2023 - 11/2016
6Lymph Node Excision (Lymph Node Dissection)
12/2023 - 03/2015
5Hepatectomy
04/2023 - 01/2014
5Castration
11/2022 - 01/2014
4Neoadjuvant Therapy
01/2023 - 11/2020
2Esophagectomy
09/2023 - 07/2023